Eli Lilly and Company
LLY
Price:
$763.98
Market Cap:
$726.09B
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various he...[Read more]
Industry
Drug Manufacturers - General
IPO Date
1972-06-01
Stock Exchange
NYSE
Ticker
LLY
The PE Ratio as of May 2024 (TTM) for Eli Lilly and Company (LLY) is 113.01
According to Eli Lilly and Company’s latest financial reports and current stock price. The company's current PE Ratio is 113.01. This represents a change of -123.72% compared to the average of -476.41 of the last 4 quarters.
Eli Lilly and Company (LLY) Historical PE Ratio (quarterly & annually)
How has LLY PE Ratio performed in the past?
The mean historical PE Ratio of Eli Lilly and Company over the last ten years is -5.31. The current 113.01 PE Ratio has changed -212861.66% with respect to the historical average. Over the past ten years (40 quarters), LLY's PE Ratio was at its highest in in the June 2022 quarter at 76.62. The PE Ratio was at its lowest in in the September 2023 quarter at -2105.01.
Average
-5.31
Median
33.84
Minimum
-435.34
Maximum
100.13
Eli Lilly and Company (LLY) PE Ratio by Quarter and Year
Discovering the peaks and valleys of Eli Lilly and Company PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 162.42%
Maximum Annual PE Ratio = 100.13
Minimum Annual Increase = -1631.09%
Minimum Annual PE Ratio = -435.34
| Year | PE Ratio | Change |
|---|---|---|
| 2023 | 100.13 | 89.55% |
| 2022 | 52.83 | 17.70% |
| 2021 | 44.88 | 81.40% |
| 2020 | 24.74 | -6.23% |
| 2019 | 26.38 | -28.30% |
| 2018 | 36.80 | -108.45% |
| 2017 | -435.34 | -1631.09% |
| 2016 | 28.43 | -23.47% |
| 2015 | 37.15 | 20.32% |
| 2014 | 30.88 | 162.42% |
Eli Lilly and Company (LLY) Average PE Ratio
How has LLY PE Ratio performed in the past?
The current PE Ratio of Eli Lilly and Company (LLY) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
65.95
5-year avg
49.79
10-year avg
-5.31
Eli Lilly and Company (LLY) PE Ratio vs. Peers
How is LLY’s PE Ratio compared to its peers?
Eli Lilly and Company’s PE Ratio is greater than Johnson & Johnson (9.47), greater than Bristol-Myers Squibb Company (-14.71), greater than AbbVie Inc. (47.70), greater than Pfizer Inc. (-542.38), less than Merck & Co., Inc. (141.33), greater than Amgen Inc. (44.36), less than Gilead Sciences, Inc. (174.30),
| Company | PE Ratio | Market cap |
|---|---|---|
| 9.47 | $364.32B | |
| -14.71 | $90.63B | |
| 47.70 | $285.35B | |
| -542.38 | $160.82B | |
| 141.33 | $325.87B | |
| 44.36 | $167.05B | |
| 174.30 | $84.28B |
Build a custom stock screener for Eli Lilly and Company (LLY) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Eli Lilly and Company using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Eli Lilly and Company (LLY) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Eli Lilly and Company or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the PE Ratio?
How can you use the PE Ratio?
What is Eli Lilly and Company's PE Ratio?
How is the PE Ratio calculated for Eli Lilly and Company (LLY)?
What is the highest PE Ratio for Eli Lilly and Company (LLY)?
What is the 3-year average PE Ratio for Eli Lilly and Company (LLY)?
What is the 5-year average PE Ratio for Eli Lilly and Company (LLY)?
How does the current PE Ratio for Eli Lilly and Company (LLY) compare to its historical average?